Falling Health Aid Threatens Millions in Africa, President Mahama Warns World Leaders

Delivering a stark warning at the 79th World Health Assembly in Geneva, President John Dramani Mahama underscored the dire consequences of dwindling global health aid for Africa. He painted a grim picture where millions face increased vulnerability due to significant cuts in international funding, a trend that threatens to unravel years of progress in critical health sectors.

“

Millions of lives across Africa are at risk as global health funding continues to decline.

Mahama did not shy away from concrete examples, illustrating the devastating impact with Ghana's experience of losing US$78 million from a defunct USAID program. This loss has crippled vital initiatives in malaria prevention, maternal and child health, and HIV/AIDS treatment. The situation in South Africa, where the withdrawal of PEPFAR funding has led to clinic closures and uncertainty for HIV patients, further underscores the continent's precarious reliance on external support.

“

The cuts in international health aid programmes could have catastrophic consequences for vulnerable populations across the continent and the world at large.

Speaking from Geneva, President Mahama articulated a powerful call for a paradigm shift. He argued that the era of donor dependency is over, urging African nations to embrace "health sovereignty." This means forging ahead with building robust, self-sustaining healthcare systems, viewing health expenditure not merely as a social cost but as a fundamental investment in economic development. Ghana's own efforts, including its primary healthcare program and the Ghana Medical Trust Fund, serve as a testament to this proactive approach. The message from Geneva is clear: Africa must take the reins of its health future, ensuring the well-being of its people as the bedrock of its progress.

“

Ghana lost US$78 million following the closure of the USAID programme, affecting malaria interventions, maternal and child healthcare, nutrition, HIV/AIDS testing, and the delivery of antiretroviral drugs.